Literature DB >> 22553691

Osteopontin expression in vitreous and proliferative retinal membranes of patients with proliferative vitreous retinopathy.

Xiao-Yi Liu1, Lei Li, Jia-Qi Yao, Xi Chen, Qing-Huai Liu.   

Abstract

AIM: To analyze osteopontin (OPN) expression in vitreous and proliferative retinal membranes of patients with proliferative vitreous retinopathy (PVR).
METHODS: A total of 54 vitreous fluid samples were obtained between 2009 and 2010, which contained 45 with PVR (group A) and 9 without PVR (group B). Enzyme-linked immunosorbent assay was applied to quantify the OPN concentrations in vitreous fluid. Four samples of proliferative retinal membrane were also obtained at the time of vitrectomy, and their contents of OPN were measured by Real-time RT-PCR.
RESULTS: The OPN levels in the vitreous fluid were 778.48±62.06ng/mL in group A and 452.99±32.52ng/mL in group B. The vitreous OPN levels in group A were significantly higher than those in group B and to rise by time in the early stages of PVR. The average OPN levels in the proliferative retinal membranes (F=0.14) were also higher than those in the retinal pigment cells (F=0) using Real-time RT-PCR.
CONCLUSION: The high vitreous and proliferative retinal membrane OPN levels in PVR suggest that OPN might promote the development of PVR. The vitreous OPN concentrations are rising by the time in the early phases of PVR.

Entities:  

Keywords:  osteopontin; proliferative retinal membranes; proliferative vitreous retinopathy; vitreous

Year:  2011        PMID: 22553691      PMCID: PMC3340871          DOI: 10.3980/j.issn.2222-3959.2011.04.17

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  9 in total

1.  In vivo osteopontin-induced macrophage accumulation is dependent on CD44 expression.

Authors:  Maria Cecilia G Marcondes; Matthew Poling; Debbie D Watry; DeShon Hall; Howard S Fox
Journal:  Cell Immunol       Date:  2008-08-03       Impact factor: 4.868

2.  Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor.

Authors:  Takeshi Kita; Yasuaki Hata; Kumiko Kano; Muneki Miura; Shintaro Nakao; Yoshihiro Noda; Hiroaki Shimokawa; Tatsuro Ishibashi
Journal:  Diabetes       Date:  2007-01       Impact factor: 9.461

3.  Elevation of plasma and cerebrospinal fluid osteopontin levels in patients with atypical teratoid/rhabdoid tumor.

Authors:  Chung-Lan Kao; Shih-Hwa Chiou; Donald Ming-Tak Ho; Yann-Jang Chen; Ren-Shyan Liu; Chih-Wen Lo; Fu-Ting Tsai; Chi-Hung Lin; Hung-Hai Ku; Shang-Ming Yu; Tai-Tong Wong
Journal:  Am J Clin Pathol       Date:  2005-02       Impact factor: 2.493

4.  Ganglion cells of the rat retina show osteopontin-like immunoreactivity.

Authors:  W K Ju; K Y Kim; J H Cha; I B Kim; M Y Lee; S J Oh; J W Chung; M H Chun
Journal:  Brain Res       Date:  2000-01-03       Impact factor: 3.252

Review 5.  Vascular endothelial growth factor and osteopontin in tumor biology.

Authors:  N Shijubo; T Uede; S Kon; M Nagata; S Abe
Journal:  Crit Rev Oncog       Date:  2000

6.  Osteopontin and alphavbeta3 integrin expression in the endometrium of infertile and fertile women.

Authors:  Gemma Casals; Jaume Ordi; Montserrat Creus; Francisco Fábregues; Roser Casamitjana; Llorenç Quinto; Elias Campo; Juan Balasch
Journal:  Reprod Biomed Online       Date:  2008-06       Impact factor: 3.828

7.  Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.

Authors:  Suzanne C Dieudonné; Ellen C La Heij; Roselie M H Diederen; Alfons G H Kessels; Albert T A Liem; Aize Kijlstra; Fred Hendrikse
Journal:  Ophthalmic Res       Date:  2007-05-25       Impact factor: 2.892

8.  Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom.

Authors:  C H Yang; T F Huang; K R Liu; M S Chen; P T Hung
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-04       Impact factor: 4.799

9.  Eta-1/osteopontin genetic polymorphism and primary biliary cirrhosis.

Authors:  Kentaro Kikuchi; Atsushi Tanaka; Hiroshi Miyakawa; Yumi Kawashima; Naomi Kawaguchi; Masanao Matsushita; M Eric Gershwin
Journal:  Hepatol Res       Date:  2003-06       Impact factor: 4.288

  9 in total
  1 in total

1.  Transcriptional Profiling Uncovers Human Hyalocytes as a Unique Innate Immune Cell Population.

Authors:  Stefaniya Konstantinova Boneva; Julian Wolf; Dennis-Dominik Rosmus; Anja Schlecht; Gabriele Prinz; Yannik Laich; Myriam Boeck; Peipei Zhang; Ingo Hilgendorf; Andreas Stahl; Thomas Reinhard; James Bainbridge; Günther Schlunck; Hansjürgen Agostini; Peter Wieghofer; Clemens A K Lange
Journal:  Front Immunol       Date:  2020-09-11       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.